shortage of glp-1 receptor agonists weight loss drugs leave users low on key nutrients, study finds GLP-1 receptor agonist shortage expected
Description
In the Phase 2 T2D trial, exploratory analyses showed significant reductions in liver fat content with retatrutide
Suddenly, people without diabetes started clamoring for a piece of the Ozempic action
M.OnsteinJ.StohrR.JankowskiV.JankowskiJ.et al
PMID: 16529340 DOI: 10.1331/154434506775268698 Tushuizen ME et al (2006): Incretin mimetics as a novel therapeutic option for hepatic steatosis
Westerterp-Plantenga, M
10.2337/diabetes.50.10.2237
